medical guideline

The Urological Society of India guidelines on management of benign prostatic hyperplasia/benign prostatic obstruction (Executive summary)

原文:2021年 发布于 Indian J Urol 37卷 第3期 210-213 浏览量:167 原文链接

作者: Urological Society of India

归属分类: 所属人体系统: 生殖 | 分类: 良性前列腺增生

关键词: Benign Prostatic Hyperplasia Guideline


These guidelines have been drafted by the Urological Society of India benign prostatic hyperplasia/obstruction ((BPH//BPO) guidelines panel and address management of BPH/BPO. The guidelines are intended for urologists and the recommendations are updated till January 2021. These will remain valid until the next update or for a maximum period of 5 years. The guidelines should not be regarded as a rigid clinical pathway for every patient and are not intended to replace clinical judgment. These guidelines should not be viewed as legal standards of care. This executive summary includes some salient aspects of the guidelines and the guideline statements.